24-24 April 2023
Qmed+
REGISTER NOW
keyboard_arrow_left See all news

Recent News

06 Feb, 2023 /
Qosina
Qosina Appoints Lee Pochter as Executive Vice President
Qosina Corp. announces the appointment of Lee Pochter as Executive Vice President
30 Jan, 2023 /
Cirtec Medical
Cirtec Medical Acquires QMD™ Precision Components Business
Cirtec Medical Corporation acquires QMD’s Precision Components business
27 Jan, 2023 /
AMADA WELD TECH
AMADA WELD TECH to Highlight Innovative Solutions for Medical Device Manufacturing at MD&M West 2023
Reliability, quality, and innovation on display in booth #2935
09 Jan, 2023 /
Qosina
Qosina Announces Partnership with ILC Dover and Expanded Portfolio of Liquid Bag Chambers
Qosina announces a partnership with ILC Dover, a leader in the innovative design and pro...
05 Jan, 2023 /
Life Science Outsourcing, Inc.
Life Science Outsourcing Completes Acquisition of J-Pac Medical
Expands into biomaterials and diagnostics end-markets, broadens service offerings, and s...
Qosina
/ 10 Jan, 2023
keyboard_arrow_left See all news

Qosina introduces Irradiate to Order service for single-use bioprocess components

Ronkonkoma, NY, USA, January 10, 2023—Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce an Irradiate to Order service for its single-use bioprocess component portfolio. This service provides Qosina’s customers a convenient way to purchase pre-irradiated single-use bioprocess components.

Customers can select from more than 1,200 components for single-use bioprocess applications and purchase small quantities of individually packaged components, irradiated at greater than 25 kilogray. Virtually any component from Qosina’s extensive product portfolio can be supplied individually packaged and irradiated to order.

Irradiated components enable process developers to build their own single-use systems using bioburden-reduced components, which have been treated with ionizing radiation to mimic the treatment of the single-use system that will be used upon scale up.

Components or systems requiring zero or low bioburden when applied in nonsterile processes do not require a validated sterile claim and may be qualified as microbially controlled. Gamma irradiation at >25 kilogray is an accepted practice to reduce or eliminate bioburden in situations where low bioburden is desired, but a formal sterile claim is not a requirement.

Learn more about Qosina’s Irradiate to Order service at www.qosina.com/irradiate-to-order.

Explore Qosina’s full line of single-use bioprocess components at www.qosina.com/bioprocess.

Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 13485, ISO 9001, ISO 22301 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 Cleanroom. To learn about Qosina’s full component offering, which includes the newest products, visit www.qosina.com or call +1 (631) 242-3000. Visit Qosmedix, Qosina’s cosmetics division, at www.qosmedix.com. Qosmedix is a certified global supplier of beauty tools and accessories to the cosmetic, skincare, spa and salon industries.

###

Contact:

Qosina Corp.
Lauren Guerra
+1 (631) 242-3000
[email protected]

Processing. Please wait.
Loading...